Vertex Pharmaceuticals (VRTX) Stock Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free VRTX Stock Alerts $397.48 -0.22 (-0.06%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Vertex Pharmaceuticals Stock Price Performance5 Day Performance-0.61%1 Month Performance-4.75%3 Month Performance-7.60%6 Month Performance+11.88%Year-To-Date Performance-2.31%1 Year Performance+17.12% Receive VRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> VRTX Stock Chart for Saturday, April, 27, 2024 VRTX Chart by TradingView Vertex Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$397.70$397.48-0.06%$399.63$393.49682,467 shs$102.73 billion04/25/2024$400.76$397.70-0.76%$403.88$393.00787,608 shs$102.79 billion04/24/2024$404.91$400.76-1.02%$406.83$399.29805,906 shs$103.58 billion04/23/2024$399.92$404.91+1.25%$406.74$403.471.07 million shs$104.65 billion04/22/2024$394.28$399.92+1.43%$406.34$396.001.39 million shs$103.36 billion04/19/2024$393.48$394.28+0.20%$396.98$391.251.34 million shs$101.91 billion Get the Latest News and Ratings for VRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$393.10$393.48+0.10%$396.14$391.02948,866 shs$101.70 billion04/17/2024$394.17$393.10-0.27%$398.11$392.03880,342 shs$101.60 billion04/16/2024$397.36$394.17-0.80%$398.49$392.81693,821 shs$101.88 billion04/15/2024$396.55$397.36+0.20%$402.49$396.691.37 million shs$102.70 billion04/12/2024$400.23$396.55-0.92%$400.14$393.761.19 million shs$102.49 billion04/11/2024$397.58$400.23+0.67%$404.69$398.851.06 million shs$103.44 billion04/10/2024$404.48$397.58-1.71%$401.00$394.811.02 million shs$102.76 billion04/09/2024$404.22$404.48+0.06%$406.45$399.30727,088 shs$104.54 billion04/08/2024$406.67$404.22-0.60%$404.60$399.00751,933 shs$104.47 billion04/05/2024$404.01$406.67+0.66%$409.93$400.83695,683 shs$105.05 billion04/04/2024$408.81$404.01-1.17%$412.64$403.15937,787 shs$104.36 billion04/03/2024$409.42$408.81-0.15%$414.96$408.25728,560 shs$105.60 billion04/02/2024$420.48$409.42-2.63%$420.87$406.73974,495 shs$105.76 billion04/01/2024$418.01$420.48+0.59%$421.45$414.74767,560 shs$108.61 billion03/29/2024$418.01$418.01$420.67$415.061.09 million shs$107.98 billion03/28/2024$417.32$418.01+0.17%$420.67$415.061.06 million shs$107.98 billion03/27/2024$418.46$417.32-0.27%$420.42$412.65905,435 shs$107.80 billion03/26/2024$416.03$418.46+0.58%$419.55$414.86952,228 shs$108.09 billion03/25/2024$415.66$416.03+0.09%$418.28$414.97721,974 shs$107.46 billion03/22/2024$415.71$415.66-0.01%$417.75$412.19821,712 shs$107.37 billion03/21/2024$412.11$415.71+0.87%$419.26$414.09894,966 shs$107.38 billion03/20/2024$415.20$412.11-0.74%$414.51$409.02793,460 shs$106.45 billion03/19/2024$411.38$415.20+0.93%$415.70$411.10859,896 shs$107.25 billion03/18/2024$407.69$411.38+0.91%$415.50$409.25926,250 shs$106.26 billion03/15/2024$408.77$407.69-0.26%$411.64$406.971.91 million shs$105.31 billion03/14/2024$413.20$408.77-1.07%$414.98$407.111.03 million shs$105.59 billion03/13/2024$412.45$413.20+0.18%$415.92$410.39764,406 shs$106.73 billion03/12/2024$414.47$412.45-0.49%$416.11$409.02866,796 shs$106.54 billion03/11/2024$413.59$414.47+0.21%$416.71$409.521.26 million shs$107.06 billion03/08/2024$410.54$413.59+0.74%$416.25$410.95814,800 shs$106.83 billion03/07/2024$411.85$410.54-0.32%$418.32$410.23923,052 shs$106.05 billion03/06/2024$415.44$411.85-0.86%$418.22$410.671.22 million shs$106.38 billion03/05/2024$424.03$415.44-2.03%$425.49$414.041.12 million shs$107.31 billion03/04/2024$432.76$424.03-2.02%$433.99$422.161.07 million shs$109.53 billionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$420.74$432.76+2.86%$433.67$422.951.09 million shs$111.79 billion02/29/2024$426.97$420.74-1.46%$429.18$420.301.85 million shs$108.68 billion02/28/2024$430.92$426.97-0.92%$433.49$425.71786,336 shs$110.29 billion02/27/2024$433.48$430.92-0.59%$437.00$430.52917,190 shs$111.31 billion02/26/2024$430.11$433.48+0.78%$434.26$425.70787,620 shs$111.97 billion02/23/2024$426.78$430.11+0.78%$434.47$429.07749,723 shs$111.10 billion02/22/2024$419.63$426.78+1.70%$429.81$419.851.09 million shs$110.24 billion02/21/2024$420.64$419.63-0.24%$424.00$414.80910,435 shs$108.39 billion02/20/2024$422.20$420.64-0.37%$425.00$416.171.06 million shs$108.66 billion02/19/2024$422.20$422.20$427.04$420.971.19 million shs$108.79 billion02/16/2024$426.29$422.20-0.96%$427.04$420.971.18 million shs$108.79 billion02/15/2024$417.88$426.29+2.01%$427.40$418.611.47 million shs$109.85 billion02/14/2024$416.04$417.88+0.44%$420.45$414.261.13 million shs$107.68 billion02/13/2024$418.53$416.04-0.59%$419.42$412.771.16 million shs$107.21 billion02/12/2024$422.91$418.53-1.04%$421.30$415.281.34 million shs$107.85 billion02/09/2024$423.06$422.91-0.04%$425.96$419.511.13 million shs$108.98 billion02/08/2024$419.08$423.06+0.95%$424.48$417.141.41 million shs$109.01 billion02/07/2024$416.13$419.08+0.71%$426.72$416.741.99 million shs$107.99 billion02/06/2024$428.89$416.13-2.98%$430.99$410.804.50 million shs$107.23 billion02/05/2024$424.68$428.89+0.99%$430.93$422.011.92 million shs$110.52 billion02/02/2024$433.87$424.68-2.12%$431.29$424.312.18 million shs$109.43 billion02/01/2024$433.38$433.87+0.11%$435.19$431.001.48 million shs$111.80 billion01/31/2024$446.08$433.38-2.85%$444.07$430.132.76 million shs$111.67 billion01/30/2024$435.82$446.08+2.35%$448.40$429.693.31 million shs$114.95 billion01/29/2024$430.17$435.82+1.31%$436.11$429.401.00 million shs$112.30 billion01/26/2024$429.96$430.17+0.05%$432.19$428.14944,498 shs$110.85 billion Related Companies: Regeneron Pharmaceuticals Stock Price Chart Bristol-Myers Squibb Stock Price Chart Sanofi Stock Price Chart GSK Stock Price Chart Zoetis Stock Price Chart Pfizer Stock Price Chart Takeda Pharmaceutical Stock Price Chart Abbott Laboratories Stock Price Chart Royalty Pharma Stock Price Chart BeiGene Stock Price Chart Receive VRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRTX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.